ICU Medical Inc. logo

ICU Medical Inc.

ICUI | NASDAQ
Chart Builder DCF Calculator
$155.22
+$2.57 (+1.68%)
At close: Sep 21, 2026, 4:00 PM ET
$155.61
+$0.39 (+0.25%)
After-hours: Sep 21, 2026, 7:30 PM ET

Market Data

Market Cap
$3.82B
Enterprise Value
$4.81B
Beta
0.76
Average Volume
300.79K
Shares Outstanding (Diluted)
25.04M
Shares Change YoY
1.36%
Institutional Ownership
N/A
Exchange
NASDAQ
ISIN
US44930G1076

Price Performance

Price Change 1M
-16.0%
Price Change 3M
14.5%
Price Change 6M
18.1%
Price Change YTD
12.1%
Price Change 1Y
17.7%
Price Change 3Y
33.3%
Price Change 5Y
-36.1%
1M CAGR (ann.)
-8.3%
1Y CAGR (ann.)
18.2%
5Y CAGR (ann.)
-9.0%
All-Time CAGR
6.8%

Valuation

PE Ratio
131.54
Forward PE
15.61
PEG Ratio
0.01
Forward PEG
11.99
PS Ratio
1.80
Forward PS
1.70
PB Ratio
1.80
P/FCF Ratio
21.50
P/Adj. FCF Ratio
30.96
P/OCF Ratio
16.43
EV/Sales
2.23
EV/EBIT
112.37
EV/EBITDA
16.17
EV/FCF
26.67
Earnings Yield
0.8%
FCF Yield
4.7%
Adj. FCF Yield
3.2%

Financial Health

Net Debt
$932.9M
Total Debt
$1.23B
Cash & Short-Term Investments
$298.3M
Total Assets
$3.97B
Current Ratio
2.43
Quick Ratio
1.21
Debt / Equity Ratio
0.59
Debt / EBITDA
4.14
Debt / FCF
6.82
OCF / Debt
0.22
Interest Coverage
1.31
Altman Z-Score
2.31
Piotroski F-Score
6

Margins & Profitability

Gross Profit Margin
37.6%
Operating Profit Margin
5.0%
EBITDA Margin
13.8%
Net Profit Margin
1.4%
FCF Margin
8.4%
Adj. FCF Margin
5.8%
SBC / Revenue
1.9%
SBC Impact (per share)
-30.6%

Returns

Return on Assets
0.8%
Return on Equity
1.4%
Return on Invested Capital
-21.7%
Return on Capital Employed
3.1%
Return on Tangible Assets
1.6%

Historical Growth (CAGR)

Revenue CAGR 3Y
-2.0%
Revenue CAGR 5Y
11.1%
Revenue CAGR 10Y
19.5%
EPS CAGR 3Y
188.7%
EPS CAGR 5Y
-24.4%
EPS CAGR 10Y
-10.0%
FCF CAGR 3Y
7.9%
FCF CAGR 5Y
0.6%
FCF CAGR 10Y
13.1%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
12
EPS Growth Next 3Y
106.1%
Revenue Growth Next 3Y
2.3%
Earnings Date
Nov 4, 2026
EPS Estimate (next Q)
$2.13
EPS Growth Est (next Q)
4.9%
Revenue Est (next Q)
$552.13M
Revenue Growth Est (next Q)
2.8%

Fair Value Estimates

Graham Number
$47.80
Graham Upside
-69.2%
Lynch Fair Value
$5.90
Lynch Upside
-96.2%
Price Target
$186.40
Price Target Upside
20.1%

Cash Flow

Operating Cash Flow
$275.28M
Free Cash Flow
$180.44M
Adj. Free Cash Flow
$125.3M
FCF Per Share
$6.11
OCF Per Share
$9.45
OCF/S Ratio
10.9%

Income Statement

Revenue
$2.16B
Gross Profit
$811.16M
Operating Income
$108.76M
EBITDA
$297.64M
Net Income
$30.09M
EPS (Diluted)
$1.18
Revenue / Employee
$166.1K
Profit / Employee
$2.31K
Employees
13,000

© 2026 bestshares.com. All rights reserved.